- Home
- RLAY vs FTAIM Comparison
RLAY vs FTAIM Comparison
Compare RLAY & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- FTAIM
- Stock Information
- Founded
- RLAY 2015
- FTAIM N/A
- Country
- RLAY United States
- FTAIM United States
- Employees
- RLAY N/A
- FTAIM 580
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- FTAIM Misc Corporate Leasing Services
- Sector
- RLAY Health Care
- FTAIM Industrials
- Exchange
- RLAY Nasdaq
- FTAIM Nasdaq
- Market Cap
- RLAY 576.1M
- FTAIM N/A
- IPO Year
- RLAY 2020
- FTAIM N/A
- Fundamental
- Price
- RLAY $3.60
- FTAIM $26.56
- Analyst Decision
- RLAY Strong Buy
- FTAIM
- Analyst Count
- RLAY 11
- FTAIM 0
- Target Price
- RLAY $18.40
- FTAIM N/A
- AVG Volume (30 Days)
- RLAY 1.5M
- FTAIM N/A
- Earning Date
- RLAY 08-05-2025
- FTAIM N/A
- Dividend Yield
- RLAY N/A
- FTAIM N/A
- EPS Growth
- RLAY N/A
- FTAIM N/A
- EPS
- RLAY N/A
- FTAIM N/A
- Revenue
- RLAY $7,679,000.00
- FTAIM N/A
- Revenue This Year
- RLAY $17.59
- FTAIM N/A
- Revenue Next Year
- RLAY N/A
- FTAIM N/A
- P/E Ratio
- RLAY N/A
- FTAIM N/A
- Revenue Growth
- RLAY N/A
- FTAIM N/A
- 52 Week Low
- RLAY $1.78
- FTAIM N/A
- 52 Week High
- RLAY $10.72
- FTAIM N/A
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- FTAIM 48.41
- Support Level
- RLAY $3.50
- FTAIM $26.50
- Resistance Level
- RLAY $3.86
- FTAIM $26.66
- Average True Range (ATR)
- RLAY 0.18
- FTAIM 0.13
- MACD
- RLAY 0.02
- FTAIM -0.04
- Stochastic Oscillator
- RLAY 65.79
- FTAIM 12.77
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.